TREAT TRIAL TO REDUCE CARDIOVASCULAR EVENTS WITH ARANESP THERAPY Trademark

Trademark Overview

On Friday, June 13, 2003, a trademark application was filed for TREAT TRIAL TO REDUCE CARDIOVASCULAR EVENTS WITH ARANESP THERAPY with the United States Patent and Trademark Office. The USPTO has given the TREAT TRIAL TO REDUCE CARDIOVASCULAR EVENTS WITH ARANESP THERAPY trademark a serial number of 78262400. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 6, 2015. This trademark is owned by Amgen Inc.. The TREAT TRIAL TO REDUCE CARDIOVASCULAR EVENTS WITH ARANESP THERAPY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials
treat trial to reduce cardiovascular events with aranesp therapy

General Information

Serial Number78262400
Word MarkTREAT TRIAL TO REDUCE CARDIOVASCULAR EVENTS WITH ARANESP THERAPY
Filing DateFriday, June 13, 2003
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 6, 2015
Registration Number3600071
Registration DateTuesday, March 31, 2009
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 29, 2005

Trademark Statements

Disclaimer with Predetermined Text"TRIAL TO REDUCE CARDIOVASCULAR EVENTS" AND "THERAPY"
Goods and ServicesMedical and scientific research, namely, conducting clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 6, 2015
Primary Code042
First Use Anywhere DateMonday, March 28, 2005
First Use In Commerce DateMonday, March 28, 2005

Trademark Owner History

Party NameAmgen Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201789

Trademark Events

Event DateEvent Description
Friday, November 6, 2015CANCELLED SEC. 8 (6-YR)
Tuesday, March 31, 2009REGISTERED-PRINCIPAL REGISTER
Monday, February 23, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, February 20, 2009ASSIGNED TO LIE
Thursday, February 12, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 22, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 21, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 21, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 18, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 18, 2008NON-FINAL ACTION E-MAILED
Friday, July 18, 2008SU - NON-FINAL ACTION - WRITTEN
Thursday, June 26, 2008STATEMENT OF USE PROCESSING COMPLETE
Friday, June 20, 2008USE AMENDMENT FILED
Friday, June 20, 2008TEAS STATEMENT OF USE RECEIVED
Tuesday, January 15, 2008EXTENSION 5 GRANTED
Tuesday, December 18, 2007EXTENSION 5 FILED
Tuesday, December 18, 2007TEAS EXTENSION RECEIVED
Monday, September 17, 2007EXTENSION 4 GRANTED
Wednesday, June 20, 2007EXTENSION 4 FILED
Wednesday, June 20, 2007TEAS EXTENSION RECEIVED
Thursday, February 1, 2007EXTENSION 3 GRANTED
Tuesday, December 5, 2006EXTENSION 3 FILED
Tuesday, December 5, 2006TEAS EXTENSION RECEIVED
Tuesday, September 26, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 17, 2006EXTENSION 2 GRANTED
Wednesday, June 21, 2006EXTENSION 2 FILED
Wednesday, June 21, 2006TEAS EXTENSION RECEIVED
Wednesday, January 18, 2006EXTENSION 1 GRANTED
Wednesday, December 21, 2005EXTENSION 1 FILED
Wednesday, December 21, 2005TEAS EXTENSION RECEIVED
Tuesday, June 21, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 29, 2005PUBLISHED FOR OPPOSITION
Wednesday, March 9, 2005NOTICE OF PUBLICATION
Tuesday, January 4, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 10, 2004ASSIGNED TO LIE
Wednesday, December 8, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 8, 2004EXAMINERS AMENDMENT E-MAILED
Wednesday, December 8, 2004EXAMINERS AMENDMENT -WRITTEN
Monday, November 29, 2004NON-FINAL ACTION E-MAILED
Monday, November 29, 2004NON-FINAL ACTION WRITTEN
Thursday, May 20, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 20, 2004PAPER RECEIVED
Tuesday, November 18, 2003NON-FINAL ACTION E-MAILED
Monday, November 3, 2003ASSIGNED TO EXAMINER

Related Keywords

aranesp therapy events cardiovascular trial reduce treat clinical trials conducting namely scientific research medical